Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Sigenics
company
About
Sigenics was established in December 2000 with one purpose in mind: to provide excellence in silicon
- 11 - 50
Highlights
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $1M
- Industries
- Aerospace,Biotechnology,Electronics,Medical,Professional Services
- Founded date
- Jan 1, 2000
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Sigenics was established in December 2000 with one purpose in mind: to provide excellence in silicon. In the beginning, Sigenics’ goal was to develop silicon devices to aid in biomedical research. We have grown to become a designer and supplier of “private-label” silicon chips for Original Equipment Manufacturers (OEM) of electronic equipment in multiple markets including: medical, aerospace, industrial, and military.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$1M
Sigenics has raised a total of
$1M
in funding over 2 rounds. Their latest funding was raised on
May 3, 2017 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 3, 2017 | Grant | $1M | 1 |
National Institutes of Health
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Sigenics is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
